Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

On Monday 29 January 2018, Chris Byrom and Stephen Thomson had great pleasure in presenting a cheque for £2000 to The Christie Charity, on behalf of the East Lancashire Masonic Charity ( ELMC ). The application was made by Chris, through his lodge, East Lancashire Centurion No 2322.
The cheque was gratefully received by Sue Bowden, Trust Fundraising Officer, who explained that the donation will contribute towards their ‘Proton Beam Therapy – Research Room Appeal’.

Chris Byrom, Sue Bowden & Steve Thomson

The UK’s first national Proton Beam Therapy ( PBT ) Centre is due to open at The Christie in the Summer 2018.   Cancer patients from across the UK will be referred here for this revolutionary treatment instead of having to travel overseas to proton centres in the US or Switzerland.   A second centre is due to open at UCLH in London in 2020.
The advantage of PBT over standard radiotherapy is that protons stop once they hit their target, depositing the majority of the dose within the tumour, rather than carrying on through the body.  It is therefore particularly successful in treating patients including children with brain tumours and tumours close to vital organs such as the spinal column.
Whilst this is an exciting and long-awaited development for cancer patients here in the UK, there is a need for further research into the way that proton therapy is delivered so they can improve outcomes for a greater number of patients in terms of improved tumour control and the reduction of problematic side effects and late effects of cancer treatment in young patients.
The government is investing £125m to fund each PBT centre.  However, the cost of on-going research falls outside Department of Health funding and so The Christie Charity is aiming to raise £5.6 million to build and equip a dedicated research space within the Christie PBT centre that will give researchers access to the beam itself.
Article by Chris Armstrong